Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Pharming Group N.V. Sponsored ADR (PHAR) had Consolidated Net Income/Loss of $1.60M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$90.20M |
|
$1.60M |
|
$14.50M |
|
$75.70M |
|
$88.90M |
|
$1.30M |
|
$1.80M |
|
$3.00M |
|
$3.00M |
|
$1.60M |
|
$1.60M |
|
|
Consolidated Net Income/Loss |
$1.60M |
$1.60M |
|
$1.30M |
|
$4.34M |
|
53.33M |
|
53.33M |
|
$0.03 |
|
$0.03 |
|
| Balance Sheet Financials | |
$280.69M |
|
$6.42M |
|
$187.29M |
|
$467.98M |
|
$93.25M |
|
$92.40M |
|
$104.25M |
|
$197.49M |
|
$270.49M |
|
$142.41M |
|
$270.49M |
|
70.78M |
|
| Cash Flow Statement Financials | |
$-7.71M |
|
$-84.84M |
|
$-11.67M |
|
$145.31M |
|
$158.28M |
|
$12.98M |
|
$6.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.01 |
|
-- |
|
-- |
|
0.25 |
|
0.36 |
|
83.92% |
|
1.44% |
|
1.44% |
|
-- |
|
3.33% |
|
1.77% |
|
$-8.03M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.22 |
|
1.58 |
|
56.85 |
|
0.59% |
|
1.12% |
|
0.34% |
|
0.44% |
|
$3.82 |
|
$-0.15 |
|
$-0.14 |
|